It’s show-me time for batoclimab, an antibody treatment from Immunovant and Roivant Sciences. Here's what you need to know.

In part 2 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the challenge inherent ...

The FDA has granted Priority Review to nipocalimab for the treatment of antibody positive patients with generalized myasthenia gravis.

For this study, outcomes were compared between 2 groups of patients with myasthenia gravis: those who developed exacerbations ...

Introduction: Eculizumab is a C5 complement inhibitor approved by the FDA for the targeted treatment of four rare diseases, paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic ...

“It can affect the eyes, causing ptosis or hanging eyelids ... In 2016, an international guidelines consensus paper from the Myasthenia Gravis Foundation of America-appointed Task Force set two goals ...

Myasthenia gravis (MG) is an autoimmune disease affecting the neuromuscular ... A 71-year-old man with a 1-year history of fluctuating right eyelid ptosis and diplopia was admitted to our hospital.

Medications for myasthenia gravis (MG) can include cholinesterase inhibitors, corticosteroids, immunosuppressants, monoclonal antibodies, and antibody fragment medications. While myasthenia gravis ...